[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 18, Issue 4 (10-2020) ::
Int J Radiat Res 2020, 18(4): 825-833 Back to browse issues page
Biokinetic modelling of 89-Zr-labelled monoclonal antibodies for dosimetry assessment in humans
H.M.H. Zakaly Ph.D., , M.Y.A. Mostafa, M. Zhukovsky
Department of Experimental Physics, Institute of Physics and Technology, Ural Federal University, Yekaterinburg, Russia , h.m.zakaly@azhar.edu.eg
Abstract:   (141 Views)
Background: Monoclonal antibodies have confirmed their merit as biotherapeutics across a wide spectrum of diseases, including cancer, heart disease, infection, and immune disorders. Materials and Methods: The dynamics of 89Zr-labelled monoclonal antibodies (MAb) after injection into the human body are modelled. This modified biokinetic model can be used for dose assessment not only for 89Zr-labelled MAb tumour visualization but also for diagnostic and radiation therapy with other MAb-labelled radionuclides. The created modified biokinetic model is based on experimental data from the literature. The cumulative 89Zr activity in organs and tissues per Bq of administered activity is calculated with the WinAct program. Results: For the organs receiving the highest radiation exposure, the average absorbed doses were estimated with IDAC 2.1 software. The results from the modelled calculations are compared with new published experimental diagnostic results from real patients. The calculations reveal that the organs which received the highest dose were the spleen, liver, kidneys, and red bone marrow (doses of 1.54, 1.33, 0.81 and 0.82 mGy/MBq, respectively). In the modified biokinetic model, the organs exhibiting the highest dose were the liver, gallbladder wall, spleen, pancreas, and kidneys (at 1.07, 0.77, 0.70, 54 and 0.44 mGy/MBq, respectively), when the injection was associated with monoclonal antibodies. Conclusion: The developed biokinetic model is in good agreement with direct measurements and can be considered a first step for simulating the radiopharmaceutical dosimetry of the 89Zr isotope.
Keywords: PET visualization, internal exposure, zirconium-89, monoclonal antibodies, absorbed dose.
Full-Text [PDF 2049 kb]   (72 Downloads)    
Type of Study: Original Research | Subject: Medical Physics
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zakaly H, Mostafa M, Zhukovsky M. Biokinetic modelling of 89-Zr-labelled monoclonal antibodies for dosimetry assessment in humans. Int J Radiat Res. 2020; 18 (4) :825-833
URL: http://ijrr.com/article-1-3301-en.html

Volume 18, Issue 4 (10-2020) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4227